WEX CEO sells 28,109 shares after option exercise
WEX’s CEO exercised expiring stock options for 28,109 shares and sold the same number under a pre-arranged Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
WEX Inc. (WEX) reports that CEO and President Melissa D. Smith exercised stock options for a total of 28,109 shares of Common Stock on September 1, 2026 at exercise prices of $104.95 and $99.69, then sold 28,109 shares in multiple open‑market transactions at weighted‑average prices between about $186 and $191 per share. These option exercises and subsequent sales occurred automatically under a Rule 10b5‑1 trading plan adopted on June 2, 2026. Footnotes also describe a prior 14,809‑share distribution from the Melissa D. Smith 2024 Trust to her direct ownership and list additional indirect holdings through her husband and several irrevocable trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) F1, F10 | 23,187 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) F1, F11 | 4,922 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 23,187 | $104.95 | $2.43M |
| Exercise | Common Stock F1 | 4,922 | $99.69 | $491K |
| Sale | Common Stock F1, F3, F4 | 180 | $186.48 | $34K |
| Sale | Common Stock F1, F4, F5 | 9,245 | $189.12 | $1.75M |
| Sale | Common Stock F1, F4, F6 | 7,575 | $189.87 | $1.44M |
| Sale | Common Stock F1, F4, F7 | 11,109 | $191.11 | $2.12M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F8 | -- | -- | -- |
| holding | Common Stock F8 | -- | -- | -- |
| holding | Common Stock F8 | -- | -- | -- |
| holding | Common Stock F9 | -- | -- | -- |
Footnotes (11)
- F1. The reported exercise of options and subsequent sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/2/2026. The reporting person exercised two stock option awards that were scheduled to expire on March 20, 2027 and May 10, 2027, respectively. The options would have been forfeited if not exercised prior to their respective expiration dates.
- F2. Reflects distribution of 14,809 shares of common stock in accordance with the terms of the trust on August 28, 2026, from the Melissa D. Smith 2024 Trust, which are now directly held by the reporting person.
- F3. The price listed is a weighted average price. These shares were sold for between $186.30 and $186.65, inclusive.
- F4. Upon request, the reporting person will provide the Securities and Exchange Commission, WEX Inc. or any security holder of WEX Inc. with full information regarding the number of shares sold at each separate purchase price.
- F5. The price listed is a weighted average price. These shares were sold for between $188.26 and $189.25, inclusive.
- F6. The price listed is a weighted average price. These shares were sold for between $189.50 and $190.19, inclusive.
- F7. The price listed is a weighted average price. These shares were sold for between $191.11 and $191.17, inclusive.
- F8. This trust was first described in a Form 4 filed by the reporting person on 06/28/2022.
- F9. This trust was first described in a Form 4 filed by the reporting person on 02/25/2026.
- F10. This stock option vested with respect to one-third of these shares each on 03/20/2018, 03/20/2019, and 03/20/2020.
- F11. Half of the performance based non-statutory stock options ("Performance-Based NSOs") reported on the reporting person's Form 4 dated May 12, 2017 (the "Original Form 4"), vested on June 26, 2020 when the Company's closing stock price was at least $149.54 for twenty consecutive trading days. Another quarter of the Performance-Based NSOs vested on December 29, 2020 when the Company's closing stock price was at least $174.45 for twenty consecutive trading days. The last remaining quarter of the Performance-Based NSOs vested on March 8, 2021 when the Company's closing stock price was at least $199.38 for twenty consecutive trading days. Please reference the Original Form 4 for further information regarding the vesting of the Performance-Based NSOs.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Performance-Based NSOs financial
non-statutory stock options financial
FAQ
What insider transactions did WEX (WEX) CEO Melissa D. Smith report on September 1, 2026?
What stock options did the WEX (WEX) CEO exercise in this Form 4?
Were Melissa D. Smith’s WEX (WEX) trades made under a Rule 10b5-1 plan?
What indirect WEX (WEX) holdings does Melissa D. Smith report?
AI-generated analysis. How Rhea-AI works. Not financial advice.